Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.